Warner Chilcott is a global specialty pharmaceutical company currently focused on the gastroenterology, women's healthcare, dermatology and urology segments of the North American and West European pharmaceuticals markets. Warner Chilcott has evolved, through a series of acquisitions and divestitures, from a small seller of undifferentiated products to a fully integrated pharmaceutical company with a broad portfolio of leading branded products. The acquisition of The Procter & Gamble Company's global branded pharmaceuticals business on October 30, 2009 at a cost of $3.1 billion transformed Warner Chilcott into a global pharmaceuticals company with significant scale and geographic reach. Warner Chilcott also acquired P&G's prescription drug product pipeline and manufacturing facilities in Puerto Rico and Germany. Today Warner Chilcott has an expanded sales force and infrastructure to better promote products in the US, major Western European and other markets, increased diversity of revenue sources, enhanced product development capabilities and a deeper product development pipeline.

Products

TASACOL® Ulcerative colitis

ACTONEL® oral contraceptive

ESTRACE® urogenital symptoms of menopause

FEMHRT® menopausal symptoms

DORYX® tetracycline-class oral antibiotic for severe acne

ENABLEX® Overactive bladder

www.wcrx.com

• Return to list